InsiderDB
Committee overlap: Finance

Sen. Ron Wyden sold Pfizer (PFE)

Sen. Ron Wyden (D-OR) · $1K–$15K · traded Jun 3, 2025

Why this is a committee overlap

Wyden is the Ranking Member of the Senate Committee on Finance, which oversees Drug Manufacturers companies. Pfizer is classified in the Drug Manufacturers - General industry.

An overlap is a fact about the trade, not evidence of wrongdoing. Committee assignments are current ones.

Transaction
Sold (full)
Amount
$1K–$15K
Owner
Spouse
Traded
Jun 3, 2025
Disclosed
Jul 2, 2025
Days to disclose
29
Asset type
Stock
As filed
Pfizer, Inc. Common Stock
Industry
Drug Manufacturers - General · Healthcare

Recent Congress trades in PFE

Company context for PFE

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. PFEContract award·USAspending

    PFE: Department of Defense contract award

    4571868312!FENTANYL 100 MCG/2 ML VIAL 2ML

    First observed: Nov 8, 2026, 7:14 PM ESTEvent / period: May 18, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  2. PFEContract award·USAspending

    PFE: Department of Defense contract award

    4571877159!CYKLOKAPRON 1,000 MG/10 ML VL 10ML

    First observed: Nov 8, 2026, 7:14 PM ESTEvent / period: May 19, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  3. PFEContract award·USAspending

    PFE: Department of Defense contract award

    4571877630!CYKLOKAPRON 1,000 MG/10 ML VL 10ML

    First observed: Nov 8, 2026, 7:14 PM ESTEvent / period: May 19, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.